Amy L. Richmond

Medicine · Health Sciences

12h-index1.5kcitations24works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(9), Immunotherapy and Immune Responses(7), Immune Cell Function and Interaction(7), Inflammatory Bowel Disease(4), T-cell and B-cell Immunology(3)

Publications24 total

Associated with T Cell Dysfunction Cells from Renal Cell Carcinoma Patients Is Elevated Levels of Select Gangliosides in T
2013
360 CAD, a Nucleotide Synthesis Enzyme, Inhibits NOD2 Anti-Bacterial Function in Human Intestinal Epithelial Cells
Gastroenterology·2012
The Nucleotide Synthesis Enzyme CAD Inhibits NOD2 Antibacterial Function in Human Intestinal Epithelial Cells
Gastroenterology·2012· 34 citedOpen Access
Alimentary Tract ATG16L1とNOD2はオートファジー依存性の抗菌機序において相互作用し、Crohn病の病態/病因に関与している
Review of gastroenterology & clinical gastroenterology and hepatology·2011
ATG16L1 and NOD2 Interact in an Autophagy-Dependent Antibacterial Pathway Implicated in Crohn's Disease Pathogenesis
Gastroenterology·2010· 359 citedOpen Access
W1239 ATG16L1 and NOD2 Interact in an Autophagy-Dependent Anti-Bacterial Pathway Implicated in Crohn's Disease Pathogenesis
Gastroenterology·2010· 1 cited
BASIC—ALIMENTARY TRACT ATG16L1 and NOD2 Interact in an Autophagy-Dependent Antibacterial Pathway Implicated in Crohn's Disease Pathogenesis
2010
Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction
The Journal of Immunology·2009· 50 citedOpen Access
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
Clinical Cancer Research·2008· 484 cited
Bortezomib (B) and doxorubicin (dox) in patients (pts) with hepatocellular cancer (HCC): A phase II trial of the Eastern Cooperative Oncology Group (ECOG 6202) with laboratory correlates
Journal of Clinical Oncology·2008· 7 cited
CD3+ LYMPHOCYTE APOPTOSIS AND GANGLIOSIDE GM2 POSITIVITY: POTENTIAL NOVEL PROGNOSTIC BIOMARKERS FOR RENAL CELL CARCINOMA
The Journal of Urology·2008
WBC changes as a pharmacodynamic marker of outcome in metastatic renal cell carcinoma (mRCC) patients (Pts) receiving sunitinib
Journal of Clinical Oncology·2007· 5 cited
GM2 Expression in Renal Cell Carcinoma: Potential Role in Tumor-Induced T-Cell Dysfunction
Cancer Research·2006· 88 cited
T regulatory cells (Treg) in patients with metastatic renal cell carcinoma (mRCC) decrease during sunitinib treatment: Correlations with clinical responses and T helper 1/T helper 2 (Th1/Th2) bias
Journal of Clinical Oncology·2006· 15 cited
GM2 Expression in Renal Cell Carcinoma Cells and T Lymphocytes: Potential Role in Tumor-Induced Immune Dysfunction
Journal of Immunotherapy·2005
Desferoxamine Protects T Cells from Glioblastoma Multiforme-mediated Apoptosis and Improves Cytolytic Activity of T Cells in Killing of Tumor Targets
Neurosurgery·2005
Glioblastomas Induce T-Lymphocyte Death by Two Distinct Pathways Involving Gangliosides and CD70
Cancer Research·2005· 140 cited
CD70 and ganglioside expression by GBM induce T-cell apoptosis which is protected by desferoxamine
Cancer Research·2005
Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma
Clinical Cancer Research·2005· 98 citedOpen Access
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
Clinical Cancer Research·2004· 75 cited
page 1 of 2Next →

Frequent Co-authors

James H. Finke(13), Patricia Rayman(9), Ronald M. Bukowski(8), Kaushik Biswas(8), Charles S. Tannenbaum(7), Craig R. Homer(6), Brian I. Rini(5), Andrew C. Novick(5), Paul Elson(4), Christine McDonald(4), Ali Chahlavi(4), Soumika Biswas(4), Nancy A. Rebert(3), Renliang Zhang(3), Gene H. Barnett(3), Walter J. Storkus(3), Tanya Das(3), Matthew N. Simmons(3), Inderbir S. Gill(3), Robert Dreicer(2)